ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Sanara MedTech Inc

Sanara MedTech Inc (SMTI)

28.88
0.08
(0.28%)
Closed July 14 4:00PM
28.52
-0.36
(-1.25%)
After Hours: 7:59PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
28.88
Bid
28.56
Ask
29.18
Volume
25,250
28.42 Day's Range 29.45
26.05 52 Week Range 46.4006
Market Cap
Previous Close
28.80
Open
28.83
Last Trade
1
@
28.88
Last Trade Time
Financial Volume
$ 724,567
VWAP
28.6957
Average Volume (3m)
18,840
Shares Outstanding
8,625,201
Dividend Yield
-
PE Ratio
-57.17
Earnings Per Share (EPS)
-0.5
Revenue
68.44M
Net Profit
-4.3M

About Sanara MedTech Inc

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver... Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel. Show more

Sector
Ortho,prosth,surg Appl,suply
Industry
Ortho,prosth,surg Appl,suply
Headquarters
Fort Worth, Texas, USA
Founded
1970
Sanara MedTech Inc is listed in the Ortho,prosth,surg Appl,suply sector of the NASDAQ with ticker SMTI. The last closing price for Sanara MedTech was $28.80. Over the last year, Sanara MedTech shares have traded in a share price range of $ 26.05 to $ 46.4006.

Sanara MedTech currently has 8,625,201 shares outstanding. The market capitalization of Sanara MedTech is $248.41 million. Sanara MedTech has a price to earnings ratio (PE ratio) of -57.17.

SMTI Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.45.0946142649227.4829.4526.252164027.82124254CS
4-1.18-3.925482368630.0631.0626.252169328.23820838CS
12-4.41-13.247221387833.2934.6726.251884029.93100611CS
26-10.58-26.8119614839.4640.7526.251594532.74352193CS
52-10.51-26.681898959139.3946.400626.051449233.99812564CS
156-8.64-23.027718550137.5250.1817.411656732.93187803CS
2600.883.142857142862853.8517.411874932.76504297CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEVVicinity Motor Corporation
$ 0.7131
(122.15%)
116.26M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
IVPInspire Veterinary Partners Inc
$ 10.52
(88.19%)
41.79M
TOYOTOYO Company Ltd
$ 2.699
(74.13%)
56.65M
NISNNiSun International Enterprise Development Group Company Ltd
$ 9.11
(51.33%)
7.4M
SISIShineco Inc
$ 0.8446
(-60.16%)
6.71M
MCACMonterey Capital Acquisition Corporation
$ 3.54
(-49.50%)
364.7k
MCACUMonterey Capital Acquisition Corporation
$ 7.64
(-28.40%)
2.61k
GENEGenetic Technologies Ltd
$ 0.80
(-27.93%)
780.46k
KZIAKazia Therapeutics Ltd
$ 0.8975
(-27.62%)
25.62M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
MAXNMaxeon Solar Technologies Ltd
$ 0.237
(-1.54%)
286.13M
NVDANVIDIA Corporation
$ 129.24
(1.44%)
251.69M
AGRIAgriFORCE Growing Systems Ltd
$ 0.1001
(21.92%)
192.82M
LCIDLucid Group Inc
$ 4.25
(25.00%)
167.79M

SMTI Discussion

View Posts
cjlct123 cjlct123 3 years ago
Anyone following this company? Seems like they are going in the right direction on all fronts. It will be nice to see how the salesforce is doing with sales.
πŸ‘οΈ0
Renee Renee 4 years ago
SMTI moved to the Nasdaq from the OTC:

https://otce.finra.org/otce/dailyList?viewType=Deletions
πŸ‘οΈ0
toddski toddski 4 years ago
Well that was a fun ride to 20. Just like I predicted, due to the buyback. Now it will be interesting to see how high it rises naturally. The ask after hours is over 36 so evidently someone thinks this will rise with time.
πŸ‘οΈ0
PithicusKong PithicusKong 5 years ago
Some individual or entity just put $ 45,000.00 into stock this AM. Seems like a vote of confidence to me.
πŸ‘οΈ0
PithicusKong PithicusKong 5 years ago
I would agree.....A company cannot grow without investment..." money begats money, and it's offspring begats more" Growth is essential.
πŸ‘οΈ0
toddski toddski 5 years ago
Significantly upped net loss, however they invested heavily in sales. So I see them back on the path to profitability within 3 to 4 quarters. I love how the directors purchased 10m worth of stock in order to fund growth, without nasty dilution. They honestly believe in the potential and put their own large sum of money out there. This will be staying in my Roth until they are bought out in a few years for North of 100 /share.

What are your thoughts?
πŸ‘οΈ0
PithicusKong PithicusKong 5 years ago
Any opinions on the 10 Q?
πŸ‘οΈ0
PithicusKong PithicusKong 5 years ago
Considering where this stock has come from in the past 12 months....there should be no concern of tax loss selling.
πŸ‘οΈ0
Golden Cross Golden Cross 5 years ago
Looking good going forward here with that $ imo...GL
πŸ‘οΈ0
PithicusKong PithicusKong 5 years ago
Market Beat Insider Trades, Tuesday Oct 22, 2019

S Oden Howell Jr

BUY....60241 shares @ $ 11.00 for a total of $ 662,600

Transaction Date: Oct 15, 2019

A chunk of change to invest, at least by my standards.
πŸ‘οΈ0
Golden Cross Golden Cross 5 years ago
News - Sanara MedTech Inc. Announces Closing of $10,000,000 Private Placement of Common Stock
Wednesday, October 16, 2019 9:00 AM
FORT WORTH, TX / ACCESSWIRE / October 16, 2019 / Sanara MedTech Inc. (OTCQB:SMTI). Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara"), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today that it has closed a private placement offering of 1,204,820 shares of its common stock at a price of $8.30 per share. All shares are being sold by Sanara as newly issued shares. The purchasers in the offering consist of related party entities to three members of Sanara's Board of Directors. The transaction was approved by all of the disinterested Directors of Sanara. The price per share was determined by a special committee of the Board comprised of disinterested Directors who considered an independent third-party valuation of the offering price and other relevant information.

The $10 million of cash proceeds of the offering are expected to be used to fund milestone payments under current and future product license agreements, repayment of indebtedness under Sanara's bank line of credit, and operating expenditures, including clinical studies and continued expansion of Sanara's sales force.

The shares of common stock sold in the transaction have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

Sanara MedTech Inc. markets and distributes wound and skincare products to physicians, hospitals, clinics, and all post-acute care settings. Its products are primarily sold in the North American advanced wound care and surgical tissue repair markets.

Information about Forward-Looking Statements

The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development and any other statements not constituting historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the Company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

Investor Contact:

Callon Nichols, Director of Investor Relations
713-826-0524
CNichols@sanaramedtech.com

SOURCE: Sanara MedTech Inc.
πŸ‘οΈ0
Harvick Harvick 5 years ago
I know growth is expensive, and sales are strong but I’m looking forward to a stronger P&L from SMTI in 2020!
πŸ‘οΈ0
TFMG TFMG 5 years ago
SMTI- BULLISH BUT WAIT FOR $10 TO GO LONG

The chart of SMTI is bullish and has built a lovely base, $10 looks like a area of strong resistance, so rather than jumping in now maybe a break above that level would provide a better entry point.
Indicators need to correct and reset for a sustained rally.

πŸ‘οΈ0
PithicusKong PithicusKong 5 years ago
Today also.....the trend is our friend.
πŸ‘οΈ0
Harvick Harvick 5 years ago
Nice little bump today!
πŸ‘οΈ0
PithicusKong PithicusKong 5 years ago
BEWARE....the devil is on the bid at $ 6.66 Must be running out of souls to gather....now expanding his/her operations. Gotta keep that heat on no matter what.
πŸ‘οΈ0
Harvick Harvick 5 years ago
IHub still doesn’t recognize the SMTI symbol so I stopped using the app
πŸ‘οΈ0
Harvick Harvick 5 years ago
What is also wired is E-Trade is showing them as being on NASDAQ but Nasdaq shows them as OTC???
πŸ‘οΈ0
toddski toddski 5 years ago
Why does no one here want to actually talk about this company? Are you all day traders?
πŸ‘οΈ0
toddski toddski 5 years ago
Thus company is so weird. They increased a credit line, and as far as I know they are still unprofitable. They want to re purchase 5 percent of the outstanding shares. At today's prices that would be over a half million dollars. I feel like that money would go to better use hiring a profits and loss specialist. I feel as though they would need to direct purchase from Mr Nixon, who would be selling at a loss with today's price. I would be very surprised why he would do that. Buying open market would drive the stock price up past $20 a share due to lack of volume. We'll see what happens.

Does anyone have any thoughts about the below?

Approval of Stock Purchase Program

The Company's Board of Directors has authorized the Company to purchase up to 5.0% of the current outstanding shares of the Company's common stock from time to time in the open market or through privately negotiated transactions at prevailing market prices, depending on market conditions. The repurchase program has no time limit and may be discontinued at any time, however the Company will use its best efforts to complete the repurchase program by the end of 2019. All shares repurchased, whether through open market or privately negotiated transactions, will be restored to the status of authorized but unissued stock.

Ron Nixon, Executive Chairman of the Board, stated, "The Board fundamentally believes that the Company's stock is undervalued at current prices and the stock repurchase program provides a meaningful way to deliver value to our shareholders."
πŸ‘οΈ0
PithicusKong PithicusKong 5 years ago
Someone did a tidy little trade early last week.....1900 shares bought at $ 3.70 early morning and sold late afternoon for $ 5.00. Talk about being nimble in the market.
πŸ‘οΈ0
Renee Renee 5 years ago
Effective June 7,2019 WNDMD will change to SMTI:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
πŸ‘οΈ0
toddski toddski 5 years ago
Really not too bad of a report. 2.49M in rev and cost of goods .29M. Margin is still looking really good, and they are growing again. They will be profitable in the next quarter or so.
πŸ‘οΈ0
PithicusKong PithicusKong 5 years ago
Some good news this AM....three new products in the works.
πŸ‘οΈ0
Harvick Harvick 5 years ago
Thank you!
πŸ‘οΈ0
Tanker12 Tanker12 5 years ago
I messaged Charles Schwab today and they are expecting it to transfer either today or tomorrow.
πŸ‘οΈ0
Harvick Harvick 5 years ago
Can anybody see the new ticker on IHub?
πŸ‘οΈ0
Harvick Harvick 5 years ago
Mine were converted on Friday.
πŸ‘οΈ0
Tanker12 Tanker12 5 years ago
Has anyone had their shares converted yet. I see they are now listed under the new ticker symbol WNDMD.
πŸ‘οΈ0
Renee Renee 5 years ago
WNDM: effective May 10,2019 Wound Management Technologies Inc. will change to Sanara MedTech Inc. and a one for 100 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
πŸ‘οΈ0
420man 420man 5 years ago
.01 incoming.
πŸ‘οΈ0
Tanker12 Tanker12 5 years ago
Thank you
πŸ‘οΈ0
davidsson10 davidsson10 5 years ago
1:100 R/S Tomorrow, per FINRA: https://otce.finra.org/otce/dailyList

WNDMD

Name Change: Sanara MedTech Inc.
πŸ‘οΈ0
Tanker12 Tanker12 5 years ago
I would agree. The volume has dropped to almost nothing . I thought the reverse spit was suppose to happen before the end if last month?
πŸ‘οΈ0
Harvick Harvick 5 years ago
I think everyone is waiting for the reverse split to happen.
πŸ‘οΈ0
BIGHUNGRY BIGHUNGRY 5 years ago
Does this stock still trade???
πŸ‘οΈ0
Tanker12 Tanker12 5 years ago
Thanks! Hopefully it will stock or better yet go up!
πŸ‘οΈ0
Harvick Harvick 5 years ago
There is your .06! Hope nobody drives it back down!
πŸ‘οΈ0
Tanker12 Tanker12 5 years ago
Thank you to who ever bought 500 shares at .05 hopefully it will hold or even help drive the price up! We should be seeing the reverse split soon!
πŸ‘οΈ0
Tanker12 Tanker12 5 years ago
I would feel better if the price was closer to .06 when the reverse stock swap takes place but not sure we will be there. The volume is almost nonexistent !
πŸ‘οΈ0
Harvick Harvick 5 years ago
Not today! I wonder what the hold up is on the reverse split?
πŸ‘οΈ0
Tanker12 Tanker12 5 years ago
The trading volume has almost stopped! I guess everyone is waiting for the reverse split.
πŸ‘οΈ0
Harvick Harvick 5 years ago
I tried...but somebody keeps driving it back down?!?!
πŸ‘οΈ0
Tanker12 Tanker12 5 years ago
Somebody is trying to help move the price up. 1000 shares at .059
πŸ‘οΈ0
Tanker12 Tanker12 5 years ago
Does any know what the date is for the reverse stock split?
πŸ‘οΈ0
Harvick Harvick 5 years ago
I threw a little more at it at the EOT to get it up to .05 but it didn’t help much! I guess we will see what happens next week!
πŸ‘οΈ0
Tanker12 Tanker12 5 years ago
I guess no one has anything to say until we have the reverse stock split . It seems as if the stock has all but stopped trading.
πŸ‘οΈ0
Tanker12 Tanker12 5 years ago
I would have to agree. It sure seems like the stock is being forced down. I would have thought that it would run up before the reverse split.
πŸ‘οΈ0
Harvick Harvick 5 years ago
After yesterday trading it looks like somebody wants the stock price at .05 at the split?!!!
πŸ‘οΈ0
toddski toddski 5 years ago
These guys lost over $500,000 in the last quarter, yet they want to reverse split their shares and "uplist". This is done with far too much haste. They need to figure out how to keep the SGA low, while maintaining margin. I likely will not buy any more until I see a positive trend with net income. All the "sales" people they added do not seem to be adding to the top or the bottom line. Michael Carmena should know better than this.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock